Skip to content

Study on the new strategy and key techniques of accurate prevention of nonalcoholic steatohepatitis based on intestinal target bacteria

Study on the new strategy and key techniques of accurate prevention of nonalcoholic steatohepatitis based on intestinal target bacteria

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800015167
Enrollment
Unknown
Registered
2018-03-11
Start date
2017-12-01
Completion date
Unknown
Last updated
2018-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

nonalcoholic steatohepatitis

Interventions

Two groups:diet and exercise

Sponsors

Affiliated Hospital of Hangzhou Normal University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18-75 years old male and female; 2. bmi<35kg/m2, in line with the 2010 Chinese Medical Association of Liver disease, fatty liver and alcoholic liver disease group developed the "nonalcoholic fatty liver disease guidelines for diagnosis and treatment" diagnostic criteria; 3. liver histology confirmed as NAFLD patients; 4. The patient understands and is willing to sign an informed consent letter.

Exclusion criteria

Exclusion criteria: 1. in the past 5 years, alcohol and/or drug abuse and dependence; 2. female average daily alcohol intake >10g/days, male average daily alcohol intake >20g/days; 3. combined with other acute and chronic active liver disease (viral hepatitis, hereditary scarlet disease, hepatolenticular degeneration, ?-resistance to trypsin deficiency, alcoholic liver disease, drug-related liver disease); 4. cirrhosis patients; 5. The Heart function is not complete, the heart function grade is 2, 3 or 4; 6. with heart pacemaker patients; 7. uncontrolled hypertension; 8. renal insufficiency, blood creatinine > normal upper limit; 9. pregnant or lactating women; 10. female early Pregnancy screening test positive, or the observation period does not want to contraceptive person; 11. The combination of HIV infection; 12. cannot accept MRI examination; 13. Long-term use of antibiotics (> 1 weeks); 14. uncontrolled hypothyroidism (upper limit of normal tsh>2 times); 15. Other researchers do not think that the completion of clinical trials; 16) can not sign the informed consent of the person.

Design outcomes

Primary

MeasureTime frame
glutamic-pyruvic transaminase;glutamic oxalacetic transaminase;Controlled attenuation index;gamma-glutamyltransferase;alkaline phosphatase;

Countries

China

Contacts

Public ContactShi Junping

Affiliated Hospital of Hangzhou Normal University

13957121199@vip.126.com+86 13957121199

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026